Maldives President Mohamed Muizzu calls India 'most trusted ally', hails first responder role
Muizzu met Prime Minister Narendra Modi at the Presidential office in Male during the Indian leader's two-day state visit to the Maldives.
Muizzu expressed his appreciation for India's commitment to being the first responder in any crisis that Male faces.
"India has long stood as the Maldives's closest and most trusted partner. Our collaboration spans a wide range of areas, from security and trade to healthcare, education and beyond, touching the everyday lives of our citizens," Muizzu said.
Apart from appreciating India for its response to the Maldives' crisis, President Muizzu also discussed various areas of cooperation with PM Modi, including development partnership, infrastructure support, capacity building, climate action, and health.
PM Modi reiterated India's commitment to support Maldives and its people, as per its requirements and priorities, and for the peace, progress and prosperity of the Indian Ocean region.
Both leaders took stock of the progress in implementing the India-Maldives Joint Vision for a 'Comprehensive Economic and Maritime Security Partnership'. Modi reiterated India's commitment to further deepen bilateral ties in keeping with its 'Neighbourhood First' and Vision MAHASAGAR policies.
Both countries called for further strengthening defence and maritime security cooperation and highlighted their collaboration under the Colombo Security Conclave.
The two leaders also reviewed the economic partnership between the two countries. The Prime Minister underscored that the proposed Free Trade Agreement and the Bilateral Investment Treaty would open new opportunities for both sides.
Noting that the two countries must take advantage of the digital economy, especially to promote tourism, he welcomed the recent understandings on UPI adoption, the acceptance of the RUPAY card, and trade in local currencies. The two leaders highlighted that the close development partnership between the countries was adding new value to the already strong people-to-people ties.
The two leaders noted that, as Global South partners, they would continue to work on issues such as climate change, renewable energy promotion, disaster risk reduction, and weather science in the interests of the planet and its people.
PM Modi thanked President Muizzu for his strong condemnation of the Pahalgam terror attack and the solidarity extended to India in the fight against terrorism.
What agreements did India and Maldives sign during PM Narendra Modi's visit to Maldives?
India and the Maldives signed six MOUs during Prime Minister Narendra Modi's visit to the country in the fields of fisheries and aquaculture, meteorology, digital public infrastructure, UPI, Indian pharmacopoeia, and concessional Line of Credit.
The new Line of Credit offers ₹4850 crores (approx $550 million) in support of infrastructure development and other activities in the Maldives. An Amendatory Agreement for the existing LoCs was also exchanged, reducing Maldives's annual debt repayment obligations by 40% (from $51 million to $29 million). Both sides also exchanged the Terms of Reference of the proposed Free Trade Agreement.
The two leaders also virtually inaugurated a roads and drainage system project in Addu city and six High Impact Community Development Projects in other cities. PM Modi handed over 3,300 social housing units and 72 vehicles for the Maldives National Defence Force and Immigration authorities.
He also handed over two units of Aarogya Maitri Health Cube (BHISHM) sets to the Government of Maldives. With state-of-the-art medical equipment as part of the cube, it can provide medical aid to 200 casualties with in-built support to sustain a crew of six medical personnel for up to 72 hours.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
27 minutes ago
- Mint
Indian shares inch lower as Kotak earnings drag financials, trade deal delay weighs
By Bharath Rajeswaran and Vivek Kumar M (Reuters) -Indian shares inched lower on Monday as weak results from Kotak Mahindra Bank weighed on sentiment, while uncertainty over trade talks with the U.S. added to overall caution. The Nifty 50 fell 0.16% to 24,798.9 points and the BSE Sensex lost 0.2% to 81,325.4 as of 10:03 a.m. IST. The broader small-caps and mid-caps lost 0.3% and 0.2%, respectively. Negotiations between India and the United States remained deadlocked over tariff cuts on agriculture and dairy products, dimming hopes of an interim deal ahead of U.S. President Donald Trump's August 1 deadline. This is in contrast to a framework trade agreement struck between the U.S. and European Union over the weekend, easing fears of a bigger trade war between the two allies, which account for almost a third of global trade. High-weightage financials and private banks lost 0.2% and 1%, respectively, dragged by a 7% fall in Kotak Mahindra Bank after it posted a drop in quarterly profit. The IT index lost 0.5%, with Tata Consultancy Services shedding 1.6% after it announced plans to reduce its workforce by 2% in fiscal year 2026. The Nifty 50 and 30-stock Sensex have logged four consecutive weekly losses due to weak earnings, foreign outflows and uncertainty over the U.S.-India trade deal. "A dull earnings season and the lingering delay in the India-U.S. trade deal have clearly cast a shadow on market sentiment. With valuations still stretched across the board, investors are understandably treading with heightened caution," said G Chokkalingam, founder and head of research at Equinomics Research. Among individual stocks, Mphasis gained 2.4% on posting quarterly results in-line with estimates and on strong deal bookings, which has boosted the IT company's revenue growth outlook. SBI Cards and Payment Services lost 3.7% after missing profit estimates in the June quarter. (Reporting by Vivek Kumar M and Bharath Rajeswaran; Editing by Eileen Soreng and Mrigank Dhaniwala)
Mint
27 minutes ago
- Mint
BEL share price: Defence stock dips ahead of Q1 results 2025. Should you buy?
Defence stock Bharat Electronics (BEL) share price fell half a percent to its day's low of ₹ 393.10 in morning trade on Monday, July 28, ahead of its June quarter (Q1FY26) results. In the last 1 year, the stock advanced over 27 percent. Moreover, it fell over 6 percent in July so far after 4 months of gains. It rose 9.5 percent in June, 22.5 percent in May, 4.2 percent in April and 22.4 percent in March. However, it started the year on a negative note, down 16 percent in February after a flat January. Seema Srivastava, Senior Research Analyst at SMC Global Securities believes, "Bharat Electronics Ltd (BEL) is expected to report a steady financial performance, supported by a strong order book and continued focus on indigenisation under the Make-in-India initiative. Despite a seasonally weaker first quarter, the company remains well-positioned due to the healthy execution of defence contracts and a robust pipeline, including large-value orders aligned with emergency procurement initiatives. Strategic investments in R&D and localisation are expected to drive long-term growth while supporting margins and profitability. Investors will likely focus on operating margin trends, working capital discipline, and capex updates." Bharat Electronics Ltd (BEL) reported strong earnings for the fourth quarter of FY25, with net profit rising 18 percent year-on-year to ₹ 2,127 crore, compared to ₹ 1,797 crore in the same period last year. The state-run defence electronics major also posted a 7 percent increase in revenue from operations at ₹ 9,150 crore, up from ₹ 8,564 crore in the year-ago quarter. On a sequential basis, BEL delivered an impressive performance. Profit after tax (PAT) surged 62 percent from ₹ 1,312 crore in Q3FY25, while revenue jumped 59 percent from ₹ 5,771 crore in the October–December 2024 period. For the full financial year ended March 2025, BEL reported a 34 percent increase in PAT to ₹ 5,323 crore, up from ₹ 3,985 crore in FY24. Revenue from operations for the year rose to ₹ 23,769 crore, a 17 percent improvement over the ₹ 20,268 crore reported in the previous financial year. As of April 1, 2025, BEL's total order book stood at a healthy ₹ 71,650 crore, indicating a strong pipeline and sustained business momentum in the defence and allied sectors. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
Economic Times
27 minutes ago
- Economic Times
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads "Another reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped sentiment," says Sunil Subramaniam , Market like you said, the question is—why were they under pressure in the first place? I'd call it the Trump effect. Mr. Trump has been talking a lot about imposing heavy pharma tariffs. He hasn't actually done anything yet, but every time he makes such statements, it creates nervousness—whether he's targeting CDMO players or generics, and how he plans to go about it. That uncertainty has impacted the pharma sector, putting it under when individual companies are reporting good numbers, the market has no choice but to buy into them—because at least those companies are indicating a positive outlook. Plus, some of them may not even be impacted by tariffs, creating a window of opportunity. Also, the pharma space includes domestic-oriented businesses like hospitals and diagnostics, which are unaffected by U.S. tariff issues. So overall, pharma remains a defensive reason for pharma's past underperformance is that FIIs were driving the selling pressure. They closely track export-oriented sectors. So the recent post-results bounce in pharma is largely driven by DIIs. FIIs still haven't firmed up their stance on India. They remain a bit cautious, especially because the delay in the BTA (Bilateral Trade Agreement) hasn't helped we need to understand the market's movement over the last three months. Post-March, FIIs were actually buyers in April and May, and even in June, though to a lesser extent. Meanwhile, if you look at the end of March, mutual fund DIIs—especially domestic mutual funds—had built up cash positions to around 7.25% of their April and May, both mutual funds and FIIs were buying, which supported the market. But starting this month, mutual fund cash levels are back down to around 5%, which is close to their lower limit. That means DIIs don't have as much cash left to deploy, apart from the fresh SIP looking at last earnings season and market levels, domestic funds have largely deployed their cash. FIIs, on the other hand, had expected some action around the BTA by July 9, which then got pushed to August 1. But now, even that deadline seems unlikely to be met. The Indian trade delegation has returned from the U.S. without a deal. Sticking points remain—like agriculture—and they won't be easy to the question now is whether Trump will extend the 10% tariff pause beyond August 1 or slap a 26% tariff on India and then negotiate, like he did with Japan—imposing higher tariffs first and then signing a deal at 19%. That kind of uncertainty around the India-U.S. BTA is keeping FIIs factor is China. While China and the U.S. haven't signed a full BTA either, they seem to have reached some understanding. Meanwhile, China's markets have been beaten down so much that the one-year forward P/E is around 11—compared to India's 22. And China's economy is about 4.5 times larger than India's. Even at 4% growth, those are big numbers. So FIIs are starting to see more value in China, pulling some attention away from as for your question on the next trigger—clearly, a breakthrough on the BTA front, like an interim deal or assurance that tariffs will be capped below 20%, could bring FIIs back. On the domestic side, it's the ongoing earnings season. Results have been mixed. The IT sector, for instance, didn't post terrible earnings, but weak guidance is weighing heavily, especially in the absence of FII DIIs have already used most of their cash, their incremental buying will depend on the inflow from SIPs and earnings results. So companies with strong earnings and forward guidance will likely get DII if the early festival season gives good signs on the consumption front, that could also be a positive trigger. Until then, expect the market to remain in a sideways, consolidative phase for some time.
